FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to an agent for treating arthritic diseases. An agent for treating arthritic diseases involves an effective amount of chondroitin sodium sulphate and at least one auxiliary substance or carrier, and also contains molybdenum in a relative amount of 0.05 mg/kg to 5 mg/kg in terms of weight of chondroitin sodium sulphate and metal or colloidal silver in a relative amount of 0.05 mg/kg to 5 mg/kg in terms of weight chondroitin sodium sulphate.
EFFECT: method described above enables higher stability of the agent for a long period of time regardless of the form of the preparation containing said agent, as well as increase the effectiveness of preparations of chondroitin sulphate in various forms and reduce negative side effects.
37 cl, 6 ex, 1 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
AGENT FOR TREATMENT OF ARTHROLOGIC DISEASES | 2015 |
|
RU2612014C1 |
PHARMACEUTICAL PREPARATION FOR TREATMENT OF ARTHROLOGICAL DISEASES | 2015 |
|
RU2743274C2 |
AGENT FOR TREATMENT OF JOINT DISEASE | 2005 |
|
RU2282437C1 |
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
REMEDY FOR TREATING DISEASES OF JOINTS | 2005 |
|
RU2275190C1 |
METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
PHARMACEUTICAL COMPOSITION FORLOCOMOTOR DISORDERS TREATMENT | 2016 |
|
RU2630064C1 |
Authors
Dates
2020-12-21—Published
2020-08-10—Filed